Literature DB >> 18509717

Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits.

Shigeyuki Takamatsu1, Osamu Matsui, Toshifumi Gabata, Satoshi Kobayashi, Miho Okuda, Takahiro Ougi, Yoshio Ikehata, Isamu Nagano, Hideo Nagae.   

Abstract

PURPOSE: To evaluate the possibility of selective hyperthermia following transcatheter arterial embolization (TAE) with ferucarbotran using a newly developed inductive heating (IH) device.
MATERIALS AND METHODS: Twelve Japanese white rabbits were separated into four groups: those treated with TAE using a mixture of ferucarbotran and lipiodol (F-L group); those treated with ferucarbotran and gelatin sponge powder; those treated with saline and lipiodol; and a control group. These four groups received IH. Nine rabbits with renal VX2 carcinoma were separated into three groups: IH after TAE (IH-TAE tumor), TAE without IH (TAE tumor), and no treatment (control tumor). The temperature of the tumor was kept at 45 degrees C for 20 min. The therapeutic effect was pathologically evaluated by TUNEL staining.
RESULTS: In the heating rates of the kidney, the F-L group showed significantly greater values than the group in which iron was not used. In the IH-TAE tumor group, tumors could be selectively heated. In TUNEL staining, the IH-TAE tumor and TAE tumor groups showed significantly greater values of apoptosis rate than in the control tumor group.
CONCLUSION: IH following TAE with a mixture of ferucarbotran and lipiodol was capable of inducing selective hyperthermia with our device. However, further investigation is needed to confirm its safety and effectiveness in the treatment of malignant neoplasms in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509717     DOI: 10.1007/s11604-007-0212-9

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  19 in total

1.  MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.

Authors:  A F Kopp; M Laniado; F Dammann; W Stern; E Grönewäller; T Balzer; C Schimpfky; C D Claussen
Journal:  Radiology       Date:  1997-09       Impact factor: 11.105

2.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.

Authors:  A Jordan; P Wust; H Fähling; W John; A Hinz; R Felix
Journal:  Int J Hyperthermia       Date:  1993 Jan-Feb       Impact factor: 3.914

3.  [Chemoembolization].

Authors:  H Nakamura; T Hashimoto; T Taguchi; H Oi; K Nakagawa; K Inoue; K Seki; S Mizumoto; H Akashi; I Tsukaguchi
Journal:  Gan To Kagaku Ryoho       Date:  1987-05

4.  Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model.

Authors:  P Moroz; S K Jones; J Winter; B N Gray
Journal:  J Surg Oncol       Date:  2001-09       Impact factor: 3.454

5.  [Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma--CT examination during the follow-up period].

Authors:  Kazuya Sugimori; Kazushi Numata; Manabu Morimoto; Mitsuaki Hirao; Kingo Hirasawa; Hiroyuki Oka; Atsushi Kokawa; Kazuhito Shirato; Toshifumi Saito; Katsuaki Tanaka; Toshio Imada; Akinori Nozawa
Journal:  Gan To Kagaku Ryoho       Date:  2004-10

Review 6.  Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). International Commission on Non-Ionizing Radiation Protection.

Authors: 
Journal:  Health Phys       Date:  1998-04       Impact factor: 1.316

7.  Phase II trial for combined external radiotherapy and hyperthermia for unresectable hepatoma.

Authors:  B S Kim; H C Chung; J S Seong; C O Suh; G E Kim
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Development of intra-arterial hyperthermia using a dextran-magnetite complex.

Authors:  M Mitsumori; M Hiraoka; T Shibata; Y Okuno; S Masunaga; M Koishi; K Okajima; Y Nagata; Y Nishimura; M Abe
Journal:  Int J Hyperthermia       Date:  1994 Nov-Dec       Impact factor: 3.914

9.  Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.

Authors:  J Overgaard; D Gonzalez Gonzalez; M C Hulshof; G Arcangeli; O Dahl; O Mella; S M Bentzen
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

10.  Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.

Authors:  T Kusumoto; Y Maehara; H Baba; I Takahashi; H Kusumoto; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more
  7 in total

1.  Simulation and experimental studies on magnetic hyperthermia with use of superparamagnetic iron oxide nanoparticles.

Authors:  Kenya Murase; Junko Oonoki; Hiroshige Takata; Ruixiao Song; Anggia Angraini; Prapan Ausanai; Taro Matsushita
Journal:  Radiol Phys Technol       Date:  2011-06-11

2.  Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.

Authors:  Itaru Sato; Masanari Umemura; Kenji Mitsudo; Mitomu Kioi; Hideyuki Nakashima; Toshinori Iwai; Xianfeng Feng; Kayoko Oda; Akiyoshi Miyajima; Ayako Makino; Maki Iwai; Takayuki Fujita; Utako Yokoyama; Satoshi Okumura; Motohiko Sato; Haruki Eguchi; Iwai Tohnai; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2014-03-12       Impact factor: 2.781

3.  Complex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potential.

Authors:  Akinaga Sonoda; Norihisa Nitta; Ayumi Nitta-Seko; Shinich Ohta; Shigeyuki Takamatsu; Yoshio Ikehata; Isamu Nagano; Jun-ichiro Jo; Yasuhiko Tabata; Masashi Takahashi; Osamu Matsui; Kiyoshi Murata
Journal:  Int J Nanomedicine       Date:  2010-08-09

4.  Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice.

Authors:  Tomoyuki Araya; Kazuo Kasahara; Shingo Nishikawa; Hideharu Kimura; Takashi Sone; Hideo Nagae; Yoshio Ikehata; Isamu Nagano; Masaki Fujimura
Journal:  Onco Targets Ther       Date:  2013-03-24       Impact factor: 4.147

5.  The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model.

Authors:  Min Jeong Jeon; Cheol-Hee Ahn; Hyeonjin Kim; In Jae Chung; Seulhee Jung; Young-Hwa Kim; Hyewon Youn; Jin Wook Chung; Young Il Kim
Journal:  J Exp Clin Cancer Res       Date:  2014-07-18

Review 6.  Magnetic Nanomaterials for Arterial Embolization and Hyperthermia of Parenchymal Organs Tumors: A Review.

Authors:  Natalia E Kazantseva; Ilona S Smolkova; Vladimir Babayan; Jarmila Vilčáková; Petr Smolka; Petr Saha
Journal:  Nanomaterials (Basel)       Date:  2021-12-15       Impact factor: 5.076

7.  Promoting the effect of microbubble-enhanced ultrasound on hyperthermia in rabbit liver.

Authors:  Yuwen Yang; Huanqian Luo; Yang Zhao; Lu Li; Yan He; Fen Xi; Hai Jin; Ruru Gao; Qiong Luo; Jianhua Liu
Journal:  J Med Ultrason (2001)       Date:  2022-01-24       Impact factor: 1.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.